Interim analysis of the randomized PATSGO trial evaluating the prolongation of adjuvant temozolomide in newly diagnosed glioblastoma patients.

Jean‐François Baurain, Laurette Renard, Daniel Devriendt et al.|Journal of Clinical Oncology|2010

Cited by 2